semaglutide vision loss linked to higher risk of problems, FDA data analysis shows Possible Link Between GLP-1 RA

See availability The latest news, articles, and resources, sent to your inbox weekly.

The FDAs ongoing safety communication on unapproved GLP-1 drugs used for weight loss makes clear that products not evaluated for safety, efficacy, or quality including compounded versions and those sold for research use only carry serious risks

Medications can be powerful tools, but they work best when they are built into a personalized medical weight loss plan instead of used as a quick fix

Although pathway bias may be advantageous in certain settings, such as in patients with concomitant cancer and diabetes, severe congenital insulin resistance syndromes typically present early in life and are frequently accompanied by impaired growth and developmental abnormalities

A full 7-day plan with high-protein meals, small portions, nausea-safe foods, and simple calorie boosts from 13001600